Avanos Medical's ROE % for the quarter that ended in Mar. 2026 was 2.61%. Avanos Medical's PB Ratio for the quarter that ended in Mar. 2026 was 0.84.
Avanos Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 3.11%.
Avanos Medical ROE % Adjusted to Book Value Related Terms
Avanos Medical ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Avanos Medical's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVNS vs IRMD, TNDM, ATEC: ROE % Adjusted to Book Value Comparison
For the Medical Devices subindustry, Avanos Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Avanos Medical's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 3.11% mean?
Avanos Medical (AVNS) has a ROE % Adjusted to Book Value of 3.11% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Avanos Medical and its competitors.
Is Avanos Medical's ROE % Adjusted to Book Value too high?
Avanos Medical's current ROE % Adjusted to Book Value is 3.11%. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's ROE % Adjusted to Book Value compare to IRMD and TNDM?
Avanos Medical's ROE % Adjusted to Book Value of 3.11% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Avanos Medical and its competitors. Avanos Medical's current ROE % Adjusted to Book Value is 3.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.42, compared to a current price of $24.95 — trading 28.5% above its estimated fair value. The current ROE % Adjusted to Book Value is 3.11%. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Avanos Medical (AVNS), the current ROE % Adjusted to Book Value is 3.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.5% above its estimated GF Value™ of $19.42.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
ROE % Adjusted to Book Value: 3.11%
GF Value™: $19.42 vs. price of $24.95 (28.5% above fair value)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
